Investment company, CoinShares, announces a profit of $32.4 million in Q2, accompanied by a 26% increase in Assets Under Management (AUM). The firm expresses intentions for a U.S. stock exchange listing.
In a significant move, CoinShares, a leading digital asset management firm, has announced plans to list on a US stock exchange in the third quarter of 2025. This decision comes as the company seeks to tap deeper capital markets and unlock greater shareholder value.
The strategic shift is driven by the growing regulatory clarity and investor appetite in the US, factors that have helped public valuations of crypto firms expand sharply. This move positions CoinShares alongside other high-profile US crypto firms, aiming to capitalise on the thriving US market.
Meanwhile, the company's physical ETP suite continues to thrive. In the first half of the year, it attracted $170 million in net inflows, making it Europe's fastest-growing platform for physically-backed, exchange-listed products. This success is attributable to a strategic product shift that captures modern institutional preference for spot-based exposure.
However, the story isn't entirely rosy for CoinShares' derivatives-based XBT products, which have seen outflows of $126 million in the same period. Contrastingly, Ethereum balances on OKX are seeing an increase, suggesting a shift in investor preference towards the second-largest cryptocurrency.
Despite the outflows, CoinShares' proprietary BLOCK Index delivered a 53.7% return during the quarter, outperforming both Bitcoin and the S&P 500. This strong performance underscores the potential of CoinShares' strategy and its ability to navigate the dynamic world of digital assets.
As CoinShares prepares for its US listing, it is expected that the company will continue to innovate and adapt to the ever-evolving landscape of the digital asset industry, providing investors with opportunities to capitalise on the growth of this burgeoning sector.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant